Totally plc
("Totally", "the Company" or "the Group")
Director / PDMR Notification
Totally (AIM: TLY), the provider of a range of services to the healthcare sector across the UK and Ireland, announces that Mike Rogers, Non-Executive Director, has purchased 25,000 ordinary shares of 10p each in the Company ( " Ordinary Shares " ) at a price of 24 pence per share.
Following this purchase, Mike Rogers has a total beneficial interest in 215,000 Ordinary Shares, equivalent to 0.12 per cent of the Company's issued share capital.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Mike Rogers | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Non-Executive Director | ||||
| b)
| Initial notification /Amendment | Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Totally plc | ||||
| b) | LEI | 213800C2NOWOH14F5J30 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a)
| Description of the financial instrument, type of instrument Identification code | Ordinary shares of 10p each in Totally plc
ISIN code : GB00BYM1JJ00 | ||||
| b) | Nature of the transaction | Purchase of ordinary shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price |
n/a | ||||
| e) | Date of the transaction | 14 January 2021 | ||||
| f) | Place of the transaction | London Stock Exchange -AIM | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
